Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FLAME: Single Blind Randomized Phase III Trial to Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer

NCT01168479 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT01168479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01168479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FLAME: Single Blind Randomized Phase III Trial to Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer
Lead sponsor
UMC Utrecht
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2009
Completion date
January 31, 2016
Enrollment
571 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

mri, prostate cancer, radiotherapy